1、许岚,王焰,吴文,阎华,高晓东,俞晴,沈志祥,糜坚青. 多发性骨髓瘤182例临床分析. 中华医学杂志,2010;90(14):972-977
2、He S, Cao Q, Qiu Y, Mi JQ, Zhang JZ, Jin M, Ge H, Emerson SG, Zhang Y, Zhang Y.. A new approach to the blocking of alloreactive T cell-mediated graft-versus-host disease by in vivo administration of anti-CXCR3 neutralizing antibody.. J Immunol.,2008;181(11):7581-92.
3、Su X, Mi J*, Yan J, Flevaris P, Lu Y, Liu H, Ruan Z, Wang X, Kieffer N, Chen SJ, Du X, and Xi X. RGT, a synthetic peptide corresponding to the integrin β3 cytoplasmic C-terminal sequence. Blood,2008;112(3):592-602
4、Mi JQ*#, Manches O, Wang J, Perron P, Weisbuch S, Marche P, Renversez JC, Bensa JC, Sotto JJ, Leroux D, Bonnefoix T. . Development of autologous cytotoxic CD4+ T clones in a human model of B-cell non-Hodgkin follicular lymphoma.. Br J Haematol,2006;135(3): 324-35.
5、糜坚青*,王振义.. 急性白血病细胞遗传及分子发病机制以及相关靶向治疗.. 内科理论与实践杂志,2006;1(1):23-29
6、Bonnefoix T, Bonnefoix P, Perron P, Mi JQ, Ng WF, Lechler R, Bensa JC, Cahn JY, Leroux D. . Quantitating effector and regulatory T lymphocytes in immune responses by limiting dilution analysis modeling.. J Immunol,2005;174(6):3421-31